Archives of Pathology & Laboratory Medicine: October 2013. Consensus Guidelines for Periprocedural Management of Coagulation Status and Hemostasis Risk in Percutaneous Image-guided Interventions. The online version of Hematology by Marshall A. Lichtman, M.D., Jerry L. Spivak, M.D., Laurence A. Boxer, M.D., Sanford J. Shattil, M.D., and Edward S. ![]() Approach Considerations, D- Dimer Testing, Coagulation Profile. Tapson VF. Acute pulmonary embolism. Problems of acute deep venous thrombosis. The interpretation of signs and symptoms. Hematopathology Links. Anemias Anemia Pathophysiologic Consequences, Classification, and Clinical Investigation (Ed Uthman, MD) Case studies in Anemia (SUNY UMU Syracuse). Principles of Blood Transfusion. Mc. Lachlin J, Richards T, Paterson JC. An evaluation of clinical signs in the diagnosis of venous thrombosis. Meignan M, Rosso J, Gauthier H, et al. Systematic lung scans reveal a high frequency of silent pulmonary embolism in patients with proximal deep venous thrombosis. ![]() ![]() Management of venous thromboembolism: a clinical practice guideline from the American College of Physicians and the American Academy of Family Physicians. Buller HR, Ten Cate- Hoek AJ, Hoes AW, et al. Safely ruling out deep venous thrombosis in primary care. Bauersachs R, Berkowitz SD, Brenner B, et al. Oral rivaroxaban for symptomatic venous thromboembolism. Oral rivaroxaban for the treatment of symptomatic pulmonary embolism. Rivaroxaban stands up to standard anticoagulation for VTE treatment. Medscape Medical News. Medscape Heartwire from Web. MD. Available at http: //www. Accessed: March 1. ![]() Jaff MR, Mc. Murtry MS, Archer SL, et al. Management of massive and submassive pulmonary embolism, iliofemoral deep vein thrombosis, and chronic thromboembolic pulmonary hypertension: a scientific statement from the American Heart Association. The oncology and hematology hub contains articles on breast cancer, lung cancer, leukemia, and lymphoma.![]() Silverstein MD, Heit JA, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ 3rd. Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 2. Useche JN, de Castro AM, Galvis GE, Mantilla RA, Ariza A. Use of US in the evaluation of patients with symptoms of deep venous thrombosis of the lower extremities. Chang R, Chen CC, Kam A, Mao E, Shawker TH, Horne MK 3rd. Deep vein thrombosis of lower extremity: direct intraclot injection of alteplase once daily with systemic anticoagulation- -results of pilot study. Biuckians A, Meier GH 3rd. Treatment of symptomatic lower extremity acute deep venous thrombosis: role of mechanical thrombectomy. Li W, Salanitri J, Tutton S, et al. Lower extremity deep venous thrombosis: evaluation with ferumoxytol- enhanced MR imaging and dual- contrast mechanism- -preliminary experience. Kakkos SK, Caprini JA, Geroulakos G, Nicolaides AN, Stansby GP, Reddy DJ. Combined intermittent pneumatic leg compression and pharmacological prophylaxis for prevention of venous thromboembolism in high- risk patients. Cochrane Database Syst Rev. Araki CT, Back TL, Padberg FT, et al. The significance of calf muscle pump function in venous ulceration. Wakefield TW, Strieter RM, Schaub R, et al. Venous thrombosis prophylaxis by inflammatory inhibition without anticoagulation therapy. Wakefield TW, Proctor MC. Current status of pulmonary embolism and venous thrombosis prophylaxis. Venous thrombosis of the lower limbs with particular reference to bed- rest. The structure and growth of valve- pocket thrombi in femoral veins. Experimental studies on venous thrombosis: effect of coagulants, procoagulants and vessel contusion. Wessler S, Reimer SM, Sheps MC. Biologic assay of a thrombosis- inducing activity in human serum. The mechanisms of canalisation in deep vein thrombosis. Gandhi RH, Irizarry E, Nackman GB, Halpern VJ, Mulcare RJ, Tilson MD. Analysis of the connective tissue matrix and proteolytic activity of primary varicose veins. Rizzi A, Quaglio D, Vasquez G, et al. Effects of vasoactive agents in healthy and diseased human saphenous veins. Monreal M, Martorell A, Callejas JM, et al. Venographic assessment of deep vein thrombosis and risk of developing post- thrombotic syndrome: a prospective study. Strandness DE Jr, Langlois Y, Cramer M, Randlett A, Thiele BL. Long- term sequelae of acute venous thrombosis. Prandoni P, Lensing AW, Cogo A, et al. The long- term clinical course of acute deep venous thrombosis. Meissner MH, Caps MT, Zierler BK, Bergelin RO, Manzo RA, Strandness DE Jr. Deep venous thrombosis and superficial venous reflux. Meissner MH, Caps MT, Zierler BK, et al. Determinants of chronic venous disease after acute deep venous thrombosis. Meissner MH, Manzo RA, Bergelin RO, Markel A, Strandness DE Jr. Deep venous insufficiency: the relationship between lysis and subsequent reflux. Caps MT, Manzo RA, Bergelin RO, Meissner MH, Strandness DE Jr. Venous valvular reflux in veins not involved at the time of acute deep vein thrombosis. Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. Relationship between changes in the deep venous system and the development of the postthrombotic syndrome after an acute episode of lower limb deep vein thrombosis: a one- to six- year follow- up. Johnson BF, Manzo RA, Bergelin RO, Strandness DE Jr. The site of residual abnormalities in the leg veins in long- term follow- up after deep vein thrombosis and their relationship to the development of the post- thrombotic syndrome. Haenen JH, Wollersheim H, Janssen MC, et al. Evolution of deep venous thrombosis: a 2- year follow- up using duplex ultrasound scan and strain- gauge plethysmography. Andriopoulos A, Wirsing P, Botticher R. Results of iliofemoral venous thrombectomy after acute thrombosis: report on 1. J Cardiovasc Surg (Torino). Zheng Y, Zhou B, Pu X. Zhonghua Yi Xue Za Zhi. Juhan C, Alimi Y, Di Mauro P, Hartung O. Surgical venous thrombectomy. Saarinen J, Kallio T, Lehto M, Hiltunen S, Sisto T. The occurrence of the post- thrombotic changes after an acute deep venous thrombosis. A prospective two- year follow- up study. J Cardiovasc Surg (Torino). Thrombolytic therapy for venous thromboembolism. Diagnosis of deep venous thrombosis and pulmonary embolism. Henriksen O, Sejrsen P. Initial treatment of venous thromboembolism. Kakkar VV, Howes J, Sharma V, Kadziola Z. A comparative double- blind, randomised trial of a new second generation LMWH (bemiparin) and UFH in the prevention of post- operative venous thromboembolism. The Bemiparin Assessment group. Heit JA, Mohr DN, Silverstein MD, Petterson TM, O'Fallon WM, Melton LJ 3rd. Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population- based cohort study. Silent pulmonary embolism. Lewandowski A, Syska- Suminska J, Dluzniewski M. Acharya G, Singh K, Hansen JB, Kumar S, Maltau JM. Catheter- directed thrombolysis for the management of postpartum deep venous thrombosis. Acta Obstet Gynecol Scand. Baarslag HJ, Koopman MM, Hutten BA, et al. Long- term follow- up of patients with suspected deep vein thrombosis of the upper extremity: survival, risk factors and post- thrombotic syndrome. Joffe HV, Kucher N, Tapson VF, Goldhaber SZ. Upper- extremity deep vein thrombosis: a prospective registry of 5. Martinelli I, Battaglioli T, Bucciarelli P, Passamonti SM, Mannucci PM. Risk factors and recurrence rate of primary deep vein thrombosis of the upper extremities. Beyth RJ, Cohen AM, Landefeld CS. Long- term outcomes of deep- vein thrombosis. Kistner RL, Ball JJ, Nordyke RA, Freeman GC. Incidence of pulmonary embolism in the course of thrombophlebitis of the lower extremities. Deep vein thrombosis and pulmonary embolism. An autopsy study with multiple regression analysis of possible risk factors. Acta Chir Scand Suppl. Treatment of oncologic emergencies. Guijarro Escribano JF, Anton RF, Colmenarejo Rubio A, et al. Superior vena cava syndrome with central venous catheter for chemotherapy treated successfully with fibrinolysis. Baltayiannis N, Magoulas D, Anagnostopoulos D, et al. Percutaneous stent placement in malignant cases of superior vena cava syndrome. Urruticoechea A, Mesia R, Dominguez J, et al. Treatment of malignant superior vena cava syndrome by endovascular stent insertion. Experience on 5. 2 patients with lung cancer. Arfvidsson B, Eklof B, Kistner RL, Masuda EM, Sato DT. Risk factors for venous thromboembolism following prolonged air travel. Coach class thrombosis. Hematol Oncol Clin North Am. Slipman CW, Lipetz JS, Jackson HB, Vresilovic EJ. Deep venous thrombosis and pulmonary embolism as a complication of bed rest for low back pain. Arch Phys Med Rehabil. Ruggeri M, Tosetto A, Castaman G, Rodeghiero F. Congenital absence of the inferior vena cava: a rare risk factor for idiopathic deep- vein thrombosis. Hamoud S, Nitecky S, Engel A, Goldsher D, Hayek T. Hypoplasia of the inferior vena cava with azygous continuation presenting as recurrent leg deep vein thrombosis. Greenfield LJ, Proctor MC. The percutaneous Greenfield filter: outcomes and practice patterns. Tsuji Y, Goto A, Hara I, et al. Renal cell carcinoma with extension of tumor thrombus into the vena cava: surgical strategy and prognosis. Stamatakis JD, Kakkar VV, Sagar S, Lawrence D, Nairn D, Bentley PG. Femoral vein thrombosis and total hip replacement. PICCs may double risk for clots in critically ill patients. Medscape Medical News from Web. MD. Available at http: //www. Accessed: June 4, 2. Chopra V, Anand S, Hickner A, et al. Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta- analysis. Alikhan R, Cohen AT, Combe S, et al. Risk factors for venous thromboembolism in hospitalized patients with acute medical illness: analysis of the MEDENOX Study. Heit JA, Elliott CG, Trowbridge AA, Morrey BF, Gent M, Hirsh J. Ardeparin sodium for extended out- of- hospital prophylaxis against venous thromboembolism after total hip or knee replacement. A randomized, double- blind, placebo- controlled trial. Chu C, Tokumaru S, Izumi K, Nakagawa K. Obesity increases risk of anticoagulation reversal failure with prothrombin complex concentrate in those with intracranial hemorrhage. Nordstrom M, Lindblad B, Bergqvist D, Kjellstrom T. A prospective study of the incidence of deep- vein thrombosis within a defined urban population. Inherited thrombophilia: resistance to activated protein C as a pathogenic factor of venous thromboembolism. Anderson FA Jr, Wheeler HB, Goldberg RJ, Hosmer DW, Forcier A. The prevalence of risk factors for venous thromboembolism among hospital patients. Warlow C, Ogston D, Douglas AS. Deep venous thrombosis of the legs after strokes. Part I- -incidence and predisposing factors. Occult cancer in patients with deep venous thrombosis. A systematic approach.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
December 2016
Categories |